Crossmark

Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2023.100214

Published Print: 2023-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Suarez-Kurtz, Guilherme http://orcid.org/0000-0002-1115-8319
Almeida, Cristina Wiggers

Chapchap, Eduardo

Schramm, Márcia Trindade

Ikoma-Coltutato, Maura Rosane Valério

Lins, Mecneide Mendes

Fonseca, Teresa Cristina Cardoso

Aguiar, Thais Ferraz

Emerenciano, Mariana http://orcid.org/0000-0003-2337-8420
Funding

Funding for this research was provided by:

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
License Information

Text and Data Mining valid from 2023-01-01

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2023-04-28
More Information

This article is maintained by: Elsevier

Article Title: Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2023.100214

Content Type: simple-article

Copyright: © 2023 HCFMUSP. Published by Elsevier España, S.L.U.